SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Algorand (ALGO) is a cryptocurrency launched in 2019. Algorand has a current supply of 10,000,000,000 with 9,078,194,480.417637 in circulation. The last known price of Algorand is 0.09693394 USD and is up 3.39 over the last 24 hours. It is currently trading on 586 active market(s) with $57,858,585.39 traded over the last 24 hours. More information can be found at http://algorand.foundation.

Algorand

ALGOs weak price action and difficulty holding or reclaiming the 10-cent area are driving debate, with bearish traders warning of further downside and bullish traders arguing the token is near a bottom and could rebound with a broader altcoin recovery. Some bulls also point to Algorands post-quantum technology and tokenization potential, but those remain longer-term arguments rather than a confirmed near-term catalyst.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candels SITC clinical and biomarker updates across its prostate, lung and glioblastoma programs have renewed attention, alongside expectations for a Q4 BLA filing for CAN-2409 after positive Phase 3 prostate results. Bulls see the data and regulatory milestone as potential value drivers, while skeptics focus on filing uncertainty, CEO transparency and dilution risk.

NextDecade Corp. is a development company, which focuses on liquefied natural gas (LNG) export projects and associated pipelines. It develops and manages land-based and floating liquefied natural gas projects in the Gulf Coast with focus on the Rio Grande LNG. The company was founded by Kathleen Eishbrenner in 2010 and is headquartered in Houston, TX.

NextDecade Corporation

Geopolitical disruption to Qatari and Middle Eastern LNG supplies has focused traders on NextDecade as a potential future U.S. LNG supplier, alongside progress at its Rio Grande project and anticipated first production in 2027. Bulls see tighter supply and stronger contracting prospects as supportive, while skeptics point to the companys lack of current production and ongoing construction, financing, and execution risks.

AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology. The company was founded in 1913 and is headquartered in Cambridge, the United Kingdom.

Astrazeneca plc

AstraZeneca PLC

A reported, non-binding AstraZeneca offer for Rhythm Pharmaceuticals is driving deal chatter, with traders debating whether a transaction will materialize and whether AZN should pursue other obesity assets. The discussion frames the potential deal as an expansion of its rare-disease and obesity portfolio, but its outcome remains uncertain.

Newmont Corp. engages in the exploration and acquisition of gold properties, containing copper, silver, lead, zinc or other metals. It operates through the following geographical segments: Papua New Guinea, Australia, Ghana, Suriname, Argentina, Peru, Mexico, Canada, and U.S. The company was founded by William Boyce Thompson on May 2, 1921 and is headquartered in Denver, CO.

Newmont Corp

Newmonts quarterly results beat expectations, but the shares are under pressure as traders focus on cost and project-spending concerns, operational risks, and a possible technical correction. Bulls point to improved cost guidance and strong gold exposure, while bearish options activity and near-term downside calls keep the debate active.

Alcoa Corp. engages in the bauxite mining, alumina refining, and aluminum smelting and casting. It operates through the Alumina and Aluminum segments. The Alumina segment consists of a refining system, including the mining of bauxite, which is then refined into alumina, a compound of aluminum and oxygen that is the raw material used by smelters to produce aluminum metal. The Aluminum segment is composed of smelting and casthouse system. The company was founded by Charles Martin Hall on July 9, 1886 and is headquartered in Pittsburgh, PA.

Alcoa Corp

Unusual options activity and volatile trading have traders divided over Alcoas direction: some expect further cyclical downside, while others point to long-term aluminum demand and expanded assets as reasons for optimism. The discussion also weighs alumina-price exposure and financing and closing considerations around the companys acquisition plans.

Listed Funds Trust - Roundhill Magnificent Seven ETF

Roundhill Magnificent Seven ETF

MAGS is drawing attention as traders debate a rotation between mega-cap tech and semiconductor/AI-infrastructure stocks, amid concern that heavy AI spending could pressure the Magnificent Sevens returns. Some see the baskets pullback as a buying opportunity and potential return to leadership, while others warn that weak momentum and doubts about AI monetization could prolong the decline.

KraneShares Trust - KraneShares CSI China Internet ETF

KraneShares CSI China Internet ETF

KWEB is drawing attention amid volatile China-tech trading and speculation that a U.S.-China deal or renewed access to Nvidia chips could support Chinese internet stocks; a sharp rally quickly reversed, fueling frustration and doubts that the move will last. The community remains split between buyers citing oversold valuations and Chinas AI potential and skeptics pointing to the sectors prolonged weakness and policy and geopolitical risks.

Fervo Energy Co. operates as a energy company. It builds and operates power facilities in extracting geothermal energy. The company was founded by Jack Norbeck and Timothy Latimer in 2017 and is headquartered in Berkeley, CA.

Fervo Energy Co. - Ordinary Shares - Class A

Fervo Energy Co

FRVO discussion centers on a bearish short report questioning whether Fervo can scale its geothermal technology, including concerns about water recovery and project execution, alongside worries about post-IPO share supply and transmission constraints. The community is divided: bulls point to Cape Stations first power and Google-backed contracts as validation, while bears say technical and commercial risks remain and cite the sharp selloff.

Berkshire Hathaway, Inc. is a holding company, which engages in the provision of property and casualty insurance and reinsurance, utilities and energy, freight rail transportation, finance, manufacturing, and retailing services. It operates through the following segments: Insurance, Burlington Northern Santa Fe, LLC (BNSF), Berkshire Hathaway Energy (BHE), Pilot Travel Centers (PTC), Manufacturing, McLane, and Service and Retailing. The Insurance segment includes the underwriting of GEICO, Berkshire Hathaway Primary Group, and Berkshire Hathaway Reinsurance Group. The BNSF segment involves the operation of railroad systems. The BHE segment focuses on regulated electric and gas utility, power generation and distribution, and real estate brokerage activities. The PTC segment consists of managing travel centers and marketing of wholesale fuel. The Manufacturing segment refers to industrial, consumer and building products, home building, and related financial services. The McLane segment covers the wholesale distribution of groceries and non-food items. The Service and Retailing segment relates to the provision of shared aircraft ownership programs, aviation pilot training, electronic components distribution, retailing businesses, automobile dealerships and trailer, and furniture leasing services. The company was founded by Oliver Chace in 1839 and is headquartered in Omaha, NE.

Berkshire Hathaway Inc. - Ordinary Shares - Class B

Berkshires latest quarterly results are drawing attention, with weaker insurance performance weighing on operating earnings while a sharp increase in share repurchases is viewed by supporters as a sign management sees value in the stock. The community is split between welcoming the buybacks and questioning whether they offset the earnings softness and limited investment opportunities.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Walt Disney, VSee Health, Genprex: Retail Most Bullish On These 3 Stocks Pre-Market

Equity

Disney’s fast-pass pilot, VSee Health’s telehealth initiative, and Genprex’s gene therapy trial progress are driving strong interest


VSee Health, Inc. is a no-code or low-code software as a service (SaaS) platform that enables clinicians and enterprises to create their telehealth workflows without programming. It engages in providing timely, quality healthcare to patients regardless of geographical barriers. The company was founded on June 24, 2024 and is headquartered in Boca Raton, FL.

VSee Health Inc.

Bullish Sentiment

Walt Disney Co. (<a class="mention" data-mention="$DIS" data-symbol-id="DIS" href="https://stocktwits.com/symbol/DIS" target="_blank">$DIS</a>)<figure class="image"><a href="https://stocktwits.com/symbol/DIS"><img style="aspect-ratio:1314/318;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/DIS_sentiment_and_message_volume_Oct_21_2024_7dcf3c3bd2.png" alt="DIS sentiment and message volume Oct 21 2024.png" width="1314" height="318"></a><figcaption>DIS sentiment and message volume Oct 21 2024 as of 7 am ET | source: Stocktwits</figcaption></figure>Sentiment on Stocktwits for Walt Disney Co. turned ‘bullish’ (69/100) early Monday before the market opened, compared to a ‘bearish’ sentiment just a day earlier. Disney’s stock has risen nearly 3.5% over the past week. Recent news driving the stock includes Disney’s announcement to pilot a new fast-pass option for rides at its U.S. theme parks, with peak pricing as high as $449. Additionally, Piper Sandler initiated coverage with a ‘Neutral’ rating and a $95 price target. The analyst noted limited upside in the next few quarters due to moderation in Disney’s experiences segment, but remains optimistic about Disney’s broader assets and recent film successes.VSee Health Inc. (<a class="mention" data-mention="$VSEE" data-symbol-id="VSEE" href="https://stocktwits.com/symbol/VSEE" target="_blank">$VSEE</a>)<figure class="image"><a href="https://stocktwits.com/symbol/VSEE"><img style="aspect-ratio:1314/318;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/GNPX_sentiment_and_message_volume_Oct_21_2024_3a5b20d8d3.png" alt="GNPX sentiment and message volume Oct 21 2024.png" width="1314" height="318"></a><figcaption>VSEE sentiment and message volume Oct 21 2024 as of 7 am ET | source: Stocktwits</figcaption></figure>VSee Health scored an ‘extremely bullish’ (97/100) sentiment on Stocktwits pre-market Monday, following a nearly 36% stock gain over the past week. The surge was driven by the announcement of a telehealth initiative in collaboration with Kwajalein Atoll Local Government (KALGOV) and Kwajalein Atoll Sustainability Laboratory (KASL). The project leverages SpaceX’s Starlink technology and VSee’s telemedicine platform to provide virtual healthcare consultations aboard a boat ambulance, aimed at improving access for Marshallese veterans and residents of the Kwajalein Atoll.Genprex, Inc. (<a class="mention" data-mention="$GNPX" data-symbol-id="GNPX" href="https://stocktwits.com/symbol/GNPX" target="_blank">$GNPX</a>)<figure class="image"><a href="https://stocktwits.com/symbol/GNPX"><img style="aspect-ratio:1314/318;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/VSEE_sentiment_and_message_volume_Oct_21_2024_70aa2e5cb4.png" alt="VSEE sentiment and message volume Oct 21 2024.png" width="1314" height="318"></a><figcaption>GNPX sentiment and message volume Oct 21 2024 as of 7 am ET | source: Stocktwits</figcaption></figure>Gene therapy company Genprex saw its Stocktwits sentiment hit ‘extremely bullish’ pre-market Monday, after a week of impressive gains over 28%. The optimism followed the company’s announcement that it had advanced to the highest dose group in its Acclaim-3 small cell lung cancer trial for Reqorsa Gene Therapy with Tecentriq, after receiving approval from a safety review committee. &nbsp;

Disney’s fast-pass pilot, VSee Health’s telehealth initiative, and Genprex’s gene therapy trial progress are driving strong interest

Walt Disney Co

Genprex Inc

Up more than 1% 

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$1.15
Prev Close	$1.15
Open	$1.00
Dividend Yield	0.00%
50-Day Moving Average	$1.61
Beta	1.14
Avg. Volume	6,063.18
PE Ratio	-0.03

52-Week High	$81.60
52-Week Low	$0.416
Market Capitalization	$926,990.00
EPS (Annual)	-$58.43
Price to Book	0.11
Revenue Per Employee	$69,943.46

Feed

News

Sentiment

Fundamentals

Info

VSEE Fundamentals